- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- Careers
- News & Insights
- About
- Languages
Evan Diamond
News 13 results
Recognition
June 17, 2020
King & Spalding IP Practices and Individuals Recognized in the IAM Patent 1000 Guide
In the News · Source: Law360
June 2, 2020
Gerald Flattmann, Lori Gordon, Vanessa Yen and Evan Diamond advise Alexion on its patent settlement with Amgen
Cases & Deals
June 1, 2020
Alexion Pharmaceuticals Secures Favorable Resolution and Termination of Challenge to SOLIRIS® Patents
Events 3 results
Conference
November 12, 2019
12th Annual King & Spalding Pharmaceutical University
Speaking Engagement
June 24, 2019
Evan Diamond, Vanessa Yen to Speak at ACI’s 2019 Summit on Biosimilars
Insights 7 results
Client Alert
April 3, 2020
D.C. Circuit Concludes that Serial Periods of Exclusivity May Be Available Under the Orphan Drug Act
Article · Source: Intellectual Property & Technology Law Journal
February 1, 2020
Federal Circuit Continues Trend of Finding Diagnostic Inventions to Be Patent-Ineligible
Article · Source: Law360
August 20, 2019
Fed. Circ.'s Arduous Legal Landscape For Diagnostic Patents
Client Alert
August 13, 2019
Federal Circuit Continues Trend of Finding Diagnostic Inventions to Be Patent-Ineligible